Previous 10 | Next 10 |
Gainers: AxoGen (AXGN) +26%. Better Therapeutics (BTTX) +15%. Intercept Pharmaceuticals (ICPT) +13%. XORTX Therapeutics (XRTX) +13%. Belite Bio (BLTE) +8%. Losers: Nephros (NEPH) -32%. BioAtla (BCAB) -27%. Outset Medical (OM) -10%. ...
Outset Medical, Inc. (OM) Q1 2022 Earnings Conference Call May 4, 2022, 5:00 PM ET Company Participants Leslie Trigg – Chair and Chief Executive Officer Jim Mazzola – Head of Investor Relations Nabeel Ahmed – Chief Financial Officers Conference Call Participants Philip Co...
Outset Medical press release (NASDAQ:OM): Q1 Non-GAAP EPS of -$0.67 misses by $0.03. Revenue of $30.55M (+33.4% Y/Y) beats by $0.44M. FY 2022 Guidance: Outset now projects revenue for the full year 2022 to range from $144 million to $150 million, which represents approximately 40% to 46% grow...
Revenue Grows 33.3% to $30.6 million, Gross Margin expands 13.2 percentage points to 14.5% Year-over-Year Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to redu...
Do you like stocks with triple-digit revenue growth? Here are three companies you might want to dig into. First up is Outset Medical (NASDAQ: OM) , a healthcare company that doubled its sales last year. The next one is Aurinia Pharmaceuticals (NASDAQ: AUPH) ; analysts ar...
With 7% of the Medicare budget spent on dialysis for chronic kidney failure patients despite representing only 1% of the Medicare population, there is a compelling reason to seek innovative solutions. The U.S. dialysis market is expected to grow 30% by 2030 as a result of an aging popul...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the BofA Securities 2022 Healthcare Conference on ...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis, today announced the appointment of Dale E. Jones to its Board of Directors. “Dale brings more than 30 years of experience in building div...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2022 after the close of t...
Patient investors can often ignore the market's short-term volatility while waiting to see how their investment thesis unfolds. Sometimes, the party has already started, and companies are beginning to see their long-term plans come to fruition. In fact, that might be an ideal time to initia...
News, Short Squeeze, Breakout and More Instantly...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2024 after the close of trading on...
MONTREAL, July 24, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “ Company ” or “ Osisko Metals ”) ( TSX-V:OM ; OTCQX:OMZNF ; FRANKFURT:0B51 ) is pleased to provide an update on the activities being carried out this summer as part of the ...